Senior Director, Marketing & Launch Lead, Pegtibatinase

San Diego, CA (Hybrid)

$219K/yr – $285K/yrSenior Level12+ years expFull time

Posted 1 month ago

Job Summary

Own the U.S. PegT marketing strategy and cross-functional launch, leading team, planning, and execution across Patient Access, Sales, Medical Affairs, and Digital Strategy.

  • Lead U.S. marketing strategy and launch, team development, and agency partnerships.
  • Collaborate across access, sales, and medical affairs to deliver market access and commercial readiness.

Job Description

Responsibilities

  • Lead the U.S. marketing strategy and execution for pegtibatinase across HCP, patient/caregiver, and patient services channels.
  • Develop product positioning, patient and physician segmentation, messaging, and market development strategies.
  • Build, lead, and develop the PegT U.S. marketing team and associated agency partnerships.
  • Lead the integrated U.S. commercial launch plan, coordinating readiness across partners in Patient Access, Sales, Commercial Insights & Operations, Medical Affairs, Patient Advocacy and Digital Strategy.
  • Chair the commercial launch team, establishing priorities, milestones, decision points, dependencies, and launch-readiness measures.
  • Partner with Patient Access and Sales leadership to integrate access, patient support, distribution, field deployment, training, and customer engagement strategies.
  • Develop relationships with thought leaders, patients, caregivers, and the HCU community to inform marketing and launch strategy.
  • Establish launch KPIs, budgets, resource plans, and operating metrics, proactively identifying and addressing execution risks.
  • Represent U.S. Marketing within the PegT cross-functional strategy team, ensuring U.S. commercial insights and priorities inform the broader program strategy.

Requirements

  • Bachelor’s degree in Business, Life Sciences, or related discipline; advanced degree preferred. Equivalent combination of education and applicable job experience may be considered.
  • 12+ years of relevant biotechnology or pharmaceutical commercial experience with demonstrated progression in responsibility.
  • Significant U.S. marketing and product strategy experience in specialty or rare disease; rare metabolic disease experience preferred.
  • Demonstrated experience preparing and launching products in the U.S.
  • Experience leading marketing teams and cross-functional launch teams in a matrixed organization.
  • Strong understanding of the pharmaceutical commercialization process, including Marketing, Market Access, Patient Services, Sales, Commercial Insights, and launch operations.
  • Strong strategic and commercial acumen with the ability to translate scientific, clinical, customer, and market insights into clear business strategies.
  • Proven ability to lead through influence across functions and drive alignment without direct authority.
  • Demonstrated success building high-performing teams and developing talent.
  • Strong scientific acumen and ability to interpret clinical data and translate implications for commercial strategy.

Benefits

  • Benefits: Our benefits include premium health, financial, work-life and well-being offerings for eligible employees and dependents, wellness and employee support programs, life insurance, disability, retirement plans with employer match and generous paid time off.
Travere Therapeutics logo

Travere Therapeutics

4.3 Glassdoor

Our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife Community Guidelines: https://travere.com/community-guidelines/

Founded in 2020
San Diego, California, USA
489 employees (23 in marketing)
83% recommend to a friend
93% CEO approval

Salaries

Posted range

$219K/yr – $285K/yr

Taken straight from the job posting.

GTM median pay in the United States

$168K/yr

Most pay falls between $121K and $220K. Based on 485 salaries.

See all Travere Therapeutics salaries

Funding

Total Funding
$1.1B
Last Raise
$125M
Post IPO Equity, 1 years ago

Funding History

  • Nov 2024
    Post IPO Equity • $125M
  • Feb 2023
    Post IPO Equity • $200M
  • Mar 2022
    Post IPO Debt • $275M

Traffic Signals

Monthly Visitors
12.7K
Traffic Source Mix
Search
44.7%
Direct
47.6%
Referral
5.5%
Social
0.5%
Paid
1.6%

Headcount Trend

Current headcount: ~489
Travere Therapeutics logo

Senior Director, Marketing & Launch Lead, Pegtibatinase

Travere Therapeutics · San Diego, CA · Hybrid